WuXi Bio taps equity market for $795m

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

WuXi Bio taps equity market for $795m

Jonathan Breen
June 30, 2020 09:30 AM
Covid_testing_575px_adobe_22June20
Speichelprobe als Abstrich von Rachen für Covid-19 Test im Labor während Coronavirus Epidemie | Robert Kneschke/Robert Kneschke - stock.adobe.com

WuXi Biologics (Cayman) bagged HK$6.17bn ($795m) on Monday after boosting the size of a new equity issuance.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Health and BiotechEquityHong Kong SARAsia Follow-ons and Rights IssuesAsiaGreater ChinaMorgan StanleyNortheast AsiaAsia PacificFollow-ons and Rights issuesEmerging MarketsSRI
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article